Skip to main content

Table 2 Change and treatment effect for body composition in men after A) 12 and B) 24 months follow-up

From: Effect of an individually tailored one-year energy balance programme on body weight, body composition and lifestyle in recent retirees: a cluster randomised controlled trial

A) Baseline Follow-up at 12 months  
    Change Treatment effect d
  intervention control intervention control   
Number 174 178 166 169   
WCa (cm) 99.2 ± 9.5 100.4 ± 9.2 -2.32 ± 3.24** -1.9 ± 3.06** -0.48 (-1.16;0.2) -0.13
BWa (kg) 85.1 ± 11.9 86.1 ± 11.4 -1.86 ± 3.08** -1.62 ± 3.03** -0.28 (-0.97;0.42) -0.08
BMIa (kg/m2) 26.7 ± 3.6 27.3 ± 3.1 -0.49 ± 1.01** -0.43 ± 0.98** -0.07 (-0.29;0.15) -0.06
HCa (cm) 101.9 ± 5.4 102.2 ± 5.3 -1.74 ± 1.70** -1.53 ± 1.88** -0.24 (-0.66;0.17) -0.12
TCa (cm) 56.8 ± 3.6 57.0 ± 3.3 -1.32 ± 1.49** -1.15 ± 1.76** -0.17 (-0.55;0.22) -0.10
SagDa (cm) 21.8 ± 2.7 22.3 ± 3.0 -1.07 ± 1.42** -1.17 ± 1.77** -0.01 (-0.33;0.31) 0.06
CCa (cm) 38.8 ± 2.7 39.1 ± 2.3 -0.93 ± 1.08** -0.85 ± 0.81** -0.09 (-0.30;0.12) -0.08
ACa (cm) 32.6 ± 2.6 32.8 ± 2.5 -0.73 ± 1.15** -0.59 ± 1.01** -0.15 (-0.38;0.08) -0.13
SBPa (mmHg) 142.7 ± 16.8 145.6 ± 17.9 -6.50 ± 9.93** -4.59 ± 12.45 -2.36 (-4.72;0.01) -0.17
DBPa (mmHg) 86.1 ± 10.1 86.1 ± 8.9 -4.03 ± 6.62** -2.79 ± 7.23** -1.25 (-2.66;0.15) -0.18
TBFa (%) 30.4 ± 4.5 30.6 ± 4.7 -0.26 ± 2.23 -0.31 ± 4.13 0.02 (-0.68;0.72) 0.02
B) Baseline Follow-up at 24 months  
    Change Treatment effect  
  intervention control intervention control   
Number 174 178 147 154   
WCa (cm) 99.2 ± 9.5 100.4 ± 9.2 -1.06 ± 3.48** -1.08 ± 3.60** -0.10 (-0.82;0.79) 0.01
BWa (kg) 85.1 ± 11.9 86.1 ± 11.4 -1.47 ± 3.66** -1.58 ± 3.96* 0.10 (-0.77;0.97) 0.03
BMIa (kg/m2) 26.7 ± 3.6 27.3 ± 3.1 -0.37 ± 1.12** -0.40 ± 1.29* 0.02 (-0.27;0.30) 0.02
HCa (cm) 101.9 ± 5.4 102.2 ± 5.3 -1.00 ± 1.88** -0.82 ± 2.29** -0.18 (-0.69;0.32) -0.09
TCa (cm) 56.8 ± 3.6 57.0 ± 3.3 -0.77 ± 1.54** -0.67 ± 2.05** -0.08 (-0.54;0.36) -0.06
SagDa (cm) 21.8 ± 2.7 22.3 ± 3.0 -0.52 ± 1.50** -0.83 ± 2.06** 0.22 (-0.19;0.62) 0.17
CCa (cm) 38.8 ± 2.7 39.1 ± 2.3 -0.43 ± 0.88** -0.41 ± 0.96** -0.04 (-0.27;0.20) -0.02
ACa (cm) 32.6 ± 2.6 32.8 ± 2.5 -0.47 ± 1.22** -0.42 ± 1.13** -0.06 (-0.33;0.21) -0.04
SBPa (mmHg) 142.7 ± 16.8 145.6 ± 17.9 -4.19 ± 12.03** -4.57 ± 14.68* -0.29 (-3.24;2.69) 0.03
DBPa (mmHg) 86.1 ± 10.1 86.1 ± 8.9 -2.89 ± 7.86** -2.54 ± 7.21** -0.38 (-1.98;1.21) -0.05
TBFa (%) 30.4 ± 4.5 30.6 ± 4.7 0.08 ± 2.49 -0.26 ± 2.80 0.32 (-0.30;0.94) 0.13
  1. aWC = waist circumference, BW = body weight, BMI = Body Mass Index, HC = hip circumference, TC = thigh circumference, SagD = sagittal diameter, CC = calf circumference. AC = arm circumference, SBP = systolic blood pressure, DBP = diastolic blood pressure, TBF = total body fat. Data are presented as mean ± standard deviation unless stated otherwise. *p < 0.05 and *p < 0.0001 for within-group-changes. Estimates for treatment effect (95% confidence interval) reflect the between-group-difference and are adjusted for baseline measurements and cluster randomisation. Cohen's d. Small: d ≤ 0.33; Medium: 0.33 <d < 0.55; Large: d ≥ 0.56.